Latest news

Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

1 2 > >>

Génome Québec is putting in place a Concertation Table on Precision Medicine

Sept. 16, 2020

Génome Québec is proud to announce the creation of a Concertation Table on Precision Medicine following the recent dissolution of the RSSPQ. A new web portal will be created soon on our website.


We encourage you to visit us regularly to find out about the new developments!

More details...

Bartha Maria Knoppers to Accept the Esteemed Till & McCulloch Award

Sept. 15, 2020

Génome Québec would like to congratulate Bartha Maria Knoppers, O.C, O.Q, PhD, Professor and Director of the Centre of Genomics and Policy at McGill University who received the prestigious 2020 Till & McCulloch Award for her exceptional ethical, legal, and social implications paper in Science entitled, Biotechnologies nibbling at the legal “human."

More details...

World Anti-Doping Agency and the Fonds de recherche du Québec have joined together to launch a Request for Applications that aims to develop biomarkers of doping

July 1, 2020

The development of novel biomarkers of doping is a key priority for anti-doping research. The challenges for the development and implementation of new biomarkers for anti-doping testing not only involve specific analytical approaches and omics technologies, but also require complementary expertise and research approaches that have been advanced in Quebec for the development of clinical biomarkers.

More details...

In2novation contributes to relaunching the economy by supporting innovation

June 29, 2020

In2novation will support entrepreneurship by fostering international collaborations between the academic and research community and the private sector.

More details...

COVID-19 - Unprecedented research combining genomics and artificial intelligence

June 17, 2020

Génome Québec is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications. 

More details...

Génome Québec commends the federal government’s contribution to research

Apr. 23, 2020

The President and CEO of Génome Québec, Daniel Coderre, applauds Ottawa’s decision to invest $40 million in research on sequencing the genomes of the virus and of patients to better understand the behaviour and evolution of the virus, as well as the different immune reactions by patients. The initiative is part of a $1 billion package of measures announced today by Prime Minister Justin Trudeau in support of medical research into COVID-19.

More details...

Congratulations to Guy Rouleau, recipient of a Gairdner Award

Apr. 3, 2020

Dr. Guy Rouleau received the Canada Gairdner Wightman Award 2020 for his outstanding work on identifying and elucidating the general mechanisms of neurological and psychiatric diseases, such as ALS (amyotrophic lateral sclerosis), autism and schizophrenia.

More details...

Marc Bergeron Appointed Vice President, Finance

Mar. 31, 2020

Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Marc Bergeron to the position of Vice President, Finance, starting April 1, 2020. Mr. Bergeron will be taking over from Claude Lamarre, who is retiring after thirteen years of service.

More details...

COVID-19 – A New Initiative from the Québec Research Sector

Mar. 26, 2020

As part of the initiatives put forward to find solutions to the COVID-19 pandemic, the Fonds de recherche du Québec and Génome Québec have tasked a group of researchers with establishing the Québec COVID Biobank.

More details...

Génome Québec activities remains operational

Mar. 19, 2020

Génome Québec is closely monitoring the development of the situation caused by COVID-19 and has taken all the necessary measures to reduce the risk of transmission. The safety of our employees and partners is an absolute priority. All travel has been cancelled; employees are all working from home and the largest gatherings that cannot be held remotely have been postponed. We are operating in strict compliance with the guidelines issued by the government.

More details...

1 2 > >>